Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Authors
Larry Diamond
News Type
Commentary
Date
Paragraphs

From a humanitarian perspective, few international policy proposals appear more compelling than debt relief for the world's poor. The poorest countries have seen their external debts spiral to the point where interest payments are crowding out desperately needed investments in roads, schools, sanitation, health care, and other social services. The majority of their people live below the poverty line, struggling to survive on a dollar or two a day. Average life expectancy is well below 60 years and declining in many countries because of AIDS. Lacking access to safe drinking water, preventive medicine, and basic education, as well as to markets, credit, and justice, people live needlessly short and degrading lives.

All News button
1
-

One of the world's greatest ethical challenges is the inequities in global health. Life expectancy in the United States is about 80 years and rising, while in many parts of the developing world, particularly in Africa as a result of HIV/AIDS, it is 40 years and falling. On the "bright side," the globalization of life sciences is key force to improve health in the developing world. For example, the rise of the Indian biotechnology industry has improved availability of vaccines and programs like the Grand Challenges in Global Health Initiative funded by the Bill and Melinda Gates Foundation provide hope for upstream discovery science against global health problems. However, on the "dark side," the globalization of life sciences poses risks to global biosecurity including bioterrorism by non-state actors.

This lecture will explore how to optimize the benefits of the "bright side," and mitigate the risks of the "dark side," of the globalization of life sciences. Dr. Singer will argue that the biological case is different from the nuclear case and demands a different approach, and explore the potential role of the United Nations in enhancing global biosecurity.

Peter A. Singer is senior scientist at the McLaughlin Rotman Centre, University Health Network; professor of medicine, University of Toronto; co-director of the Canadian Program in Genomics and Global Health; and a distinguished investigator of the Canadian Institutes of Health Research. He studied internal medicine at the University of Toronto, medical ethics at the University of Chicago, public health at Yale University, and management at Harvard Business School. Between 1995 and 2006, Singer was Sun Life Financial Chair in Bioethics, director of the University of Toronto Joint Centre for Bioethics, and director of the World Health Organization Collaborating Centre for Bioethics at the University of Toronto.

History Corner, Building 200, Room 002

Peter A. Singer Senior Scientist, McLaughlin Rotman Centre, University Health Network, and Professor of Medicine Speaker University of Toronto
Lectures
Submitted by fsid9admin on

TeachAIDS and SPICE have collaborated to provide pedagogically-grounded interactive health materials that promote a powerful and dynamic approach to HIV/AIDS education. Built by an interdisciplinary team of experts at Stanford University, these high-quality materials have been rigorously tested and are used in dozens of countries around the world. Given the tremendous need for these materials, TeachAIDS and SPICE are offering this unit for free download.

Aamotveien 19a
N-0880 Oslo
Norway

(47) 92222096
0
Adjunct Affiliate at the Center for Health Policy and the Department of Health Policy
charlotte_haug_headshot-2023.jpg

Charlotte J. Haug has an MD and PhD from the University of Oslo, Norway and a MSc in Health Services Research from Stanford University, USA. She is Exectutive Editor of NEJM AI, International Correspondent at the New England Journal of Medicine, Senior Scientist at SINTEF Digital Health (Norway), and Adjunct Affiliate of Stanford Health Policy, Stanford University.


Dr Haug has worked in clinical medicine and research in Norway and with organization, priority setting and supervision of healthcare systems both nationally and internationally. From 2002 - 2015, she was Editor-in-Chief of the Journal of the Norwegian Medical Association and a member of the International Committee of Medical Journal Editors (ICMJE, the “Vancouver group”). She was a Council Member of the Committee on Publication Ethics (COPE) from 2005-2015 and Vice-Chair of COPE from 2012-2015. She received the Council of Science Editors (CSE) Award for Meritorious Achievement in 2013, and was on the International Advisory Board of the 4th World Conference on Research Integrity in Rio de Janeiro, Brazil, in 2015. She has worked extensively with issues concerning scientific publication, research and publication ethics with a particular emphasis on how to handle and optimize the use personal data collected in clinical and clinical research settings while preserving the individuals’ right to privacy.

A major interest going forward is the application of AI in clinical medicine and health care in a responsible and ethical way to protect privacy, to avoid bias and exploitation, and provide better care to those who do not get the best care now.

 

CV

Via Columbia 2
00133 Rome Italy

+39 06 7259 5606 +39 06 2020687
0
Associate Professor, Department of Economics and Finance - University of Roma
Atella,_Vincenzo_BW3x4.jpg MSc

Vincenzo Atella is Associate Professor of Economics at the University of Rome "Tor Vergata" where he teaches Macroeconomics and courses in Applied Health Economics at graduate and post graduate level. He is also adjunct associate of the Center for Health Policy at Stanford where he has been visiting professor in different occasions.
Currently, he is CEIS Tor Vergata Director and Scientific Director of the Farmafactoring Foundation, member of SIVEAS (Health Care Services National Evaluation System) of the Ministry of Health, chief economist of the Italian Association of General Practitionners (Società Italiana di Medicina Generale – SIMG) and member and co-founder of the Italian Public Affair Association.


In the recent past he has been member of the International Committee of Experts advising IQWiG (the German Agency for Health Care) for setting national guidelines for Economic Evaluation and member of the Italian Committee for Drug Price appointed by the Ministry of Treasury. He also served as member of the “Strategic Evaluation Committee” of the Italian Drug Agency (AIFA), and has been consultant for the Italian Regional Agency for Health Care Services (http://www.assr.it/), the National Institute of Health (http://www.iss.it/), the WHO and the World Bank. Prof. Atella has been coordinator of a large European Research Network called TECH Europe (http://healthpolicy.fsi.stanford.edu/tech/) which has received financial support by the European Science Foundation. His most recent research activity has focused on poverty, income distribution and health economics. In this last field his research deals with the introduction of new technologies in the health sector, the impact of different co-payment systems on pharmaceutical decision making by physicians and on drug consumption by patients, forecasting health expenditure and with health related income inequalities. The results of this research activity have been published on several international refereed journals as well books.

Director of the Centre for Economic and International Studies (CEIS) at the University of Rome “Tor Vergata”
Adjunct Affiliate at the Center for Health Policy and the Department of Medicine
CV
-

Suicide bombings targeting Israeli civilians were once the favored tactic of Palestinian terrorists. Israeli deaths from suicide bombings peaked in the spring of 2002, but Israeli countermeasures dramatically lowered the number of successful suicide bombings since then. This talk will assess the impact of various countermeasures on suicide bombing rates with an eye towards understanding the decline in successful suicide bombings in Israel.

Edward H. Kaplan is the William N. and Marie A. Beach Professor of Management Sciences at the Yale School of Management, a professor of public health at the Yale School of Medicine, and professor of engineering in the Yale Faculty of Engineering. An elected member of the National Academy of Engineering and the Institute of Medicine, Kaplan uses operations research and statistical methods to study problems in public policy and management. His earlier work was devoted to evaluating HIV prevention programs, while his more recent studies focus on counterterror topics such as the tactical prevention of suicide bombings and response logistics in the event of a bioterror attack. He has also dabbled in predicting the outcomes of presidential elections and NCAA basketball tournaments. His efforts have been recognized with several awards in the fields of operations research and public health.

Reuben W. Hills Conference Room

Edward Kaplan William N. and Marie A. Beach Professor of Management Sciences, Professor of Public Health, and Professor of Engineering Speaker Yale University
Seminars
-

Despite predictions of their eradication in the 1960s, infectious diseases remain a significant cause of global health, economic, and social problems. There has been a renewed focus on the background "matrix" of infections that occur around the globe, as well as on emerging, re-emerging, and deliberately emerging (i.e. bioterror) agents. This talk will provide a global health perspective on infectious diseases in 2007, and highlight the lessons that can be learned from three conditions (HIV/AIDS, influenza, and SARS).

Daniel Libraty is an associate professor of medicine at the University of Massachusetts Medical School. He is a member of the Center for Infectious Disease and Vaccine Research (CIDVR), and the Division of Infectious Diseases/Department of Medicine. He received his MD degree from the University of California, San Diego. He completed his post-graduate residency in internal medicine at the University of California, San Francisco, and obtained subspecialty training in infectious diseases at the University of California, Los Angeles. His research focuses on understanding the protective and pathogenic human immune responses to emerging and re-emerging viral diseases such as dengue, hantavirus, SARS, and influenza. He has lived and traveled extensively throughout Southeast Asia and other parts of the world in the course of working on these infectious diseases.

Reuben W. Hills Conference Room

Daniel Libraty Associate Professor, Department of Medicine Speaker University of Massachusetts
Seminars
News Type
News
Date
Paragraphs

Dr. Karen Eggleston will join the Shorenstein Asia-Pacific Research Center as a center fellow on July 1, 2007. Dr. Eggleston will lead the center's program on comparative health care in East Asia.

Dr. Eggleston's research focuses on comparative healthcare systems and their link to broader social protection policies during economic development and transition from central planning to market-based economies; payment incentives and their impact on healthcare insurer and provider behavior; the market structure of healthcare, including competition, integration, ownership, and healthcare productivity; and incentives surrounding health behaviors such as the spread of HIV/AIDS, overuse of antibiotics, and smoking. She studied in China for two years and was a Fulbright scholar in Korea.

Eggleston earned her Ph.D. in public policy from Harvard University in 1999. She has an M.A. in economics and another in Asian studies from the University of Hawaii, Economics (August 1995 and May 1992, respectively.) She is currently an assistant professor of economics at Tufts University in Boston. Dr. Eggleston joined the faculty at Tufts in 1999.

Currently, Dr. Eggleston is a research associate at the Kennedy School of Government at Harvard University and an academic program coordinator at the Kennedy School Health Care Delivery Policy Program also at Harvard. Dr. Eggleson has been a research associate at the China Academy of Health Policy (CAHP) at Peking University, Beijing, China since 2003 and in the summer of 2004 she was a consultant to the World Bank on their project on health service delivery and the rural health sector.

"Karen will be a great addition to the center," says director of the center, Gi-Wook Shin.

All News button
1
-

Executive Director of UNAIDS since its creation in 1995 and Under Secretary-General of the United Nations, Dr. Peter Piot comes from a distinguished academic and scientific career focusing on AIDS and women's health in the developing world.

Drawing on his skills as a scientist, manager, and activist, Dr. Piot has challenged world leaders to view AIDS in the context of social and economic development as well as security.

Under his leadership, UNAIDS has become the chief advocate of worldwide action against AIDS. It has brought together ten organizations of the United Nations system around a common agenda on AIDS, spearheading UN reform.

Dr. Piot earned a medical degree from the University of Ghent, a PhD in Microbiology from the University of Antwerp, Belgium and was a Senior Fellow at the University of Washington in Seattle. After graduating from medical school, Dr. Piot co-discovered the Ebola virus in Zaire in 1976.

In the 1980s, Dr. Piot launched and expanded a series of collaborative projects in Burundi, Côte d'Ivoire, Kenya, Tanzania, and Zaire. Projet SIDA (Project AIDS) in Kinshasa, Zaire, was the first international project on AIDS in Africa and is widely acknowledged as having provided the foundations of our understanding of HIV infection in Africa. He was a professor of microbiology, and of public health at the Institute of Tropical Medicine, in Antwerp, and the Universities of Nairobi, Brussels, and Lausanne.

In 1992, Dr. Piot joined the Global Programme on AIDS of the World Health Organization, in Geneva, as Associate Director.

Born in 1949 in Belgium, Dr. Piot is fluent in three languages and is the author of 16 books and more than 500 scientific articles. He has received numerous awards for scientific and societal achievement, and was made a Baron by King Albert II of Belgium in 1995. He is a member of the Institute of Medicine of the National Academy of Sciences of the United States and the Royal Academy of Medicine of Belgium, and is a Fellow of the Royal College of Physicians of London, UK.

For more information about Dr. Piot, read "The Life of a Virus Hunter" from Newsweek's special edition of May 15, 2006, AIDS at 25.

Kresge Auditorium

Dr. Peter Piot Executive Director, UNAIDS and Under Secretary-General, United Nations Speaker
Lectures
Subscribe to Health and Medicine